Clinical Trial Update: The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effect of azithromycin on bronchopulmonary dysplasia in extremely and very preterm infants; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Intraventricular Hemorrhage
• Necrotizing Enterocolitis

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Indonesia University | Conditions: Bronchopulmonary Dysplasia, Intraventricular Hemorrhage | Phase 4 | Status: COMPLETED